Package Leaflet: Information for the User
Excedite 250 mg / 250 mg / 65 mg film-coated tablets
Acetylsalicylic acid / Paracetamol / Caffeine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Each tablet contains three active substances: acetylsalicylic acid, paracetamol, and caffeine.
Excedite is used to treat acute headache and migraine attacks with or without aura (symptoms such as headache, nausea, and sensitivity to light and sound).
Do not take Excedite if:
Warnings and precautions
Excedite contains paracetamol. Do not take more than the recommended dose, as this can cause serious liver damage.
Acetylsalicylic acid can cause bleeding. You should inform your doctor if you experience any unusual bleeding.
The following are reasons why Excedite may not be suitable for you. Before taking this medicine, you should consult your doctor if:
During treatment with Excedite, inform your doctor immediately if:
If you have serious diseases, such as severe kidney failure or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you suffer from malnutrition, chronic alcoholism, or are also taking flucloxacillin (an antibiotic). A serious disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling unwell (nausea) and vomiting.
Other precautions
As with any type of pain reliever, taking Excedite too often (which means taking more than 10 days a month of this medicine) coinciding with chronic headaches (15 days a month or more), for more than 3 months, could worsen your headache or migraine. If you think this may be your case, contact your doctor for advice. You may need to stop taking Excedite to resolve this problem.
Excedite may reduce the symptoms of an infection (e.g., headache, high temperature) and therefore may make it more difficult to detect. If you feel unwell and need to see a doctor, remember to tell them that you are taking this medicine.
Excedite may interfere with laboratory test results. If you are going to have a blood test, urine test, or other laboratory test, remember to inform that you are taking Excedite.
Excedite contains 0.03 mg of benzoic acid (E 210) per tablet. Benzoic acid may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).
Other medicines and Excedite
Tell your doctor or pharmacist if you are using or have recently used other medicines, including those obtained without a prescription.
In particular, tell your doctor if you are taking any of the following medicines:
Taking Excedite with food and drink
If you consume 3 or more alcoholic beverages per day, consult your doctor before taking this medicine or any other pain reliever or fever-reducing medicine. Paracetamol and acetylsalicylic acid can cause liver damage and stomach bleeding.
The recommended dose of this product contains approximately the same amount of caffeine as a cup of coffee. Limit your intake of medicines, foods, or beverages that contain caffeine during treatment with this medicine, as too much caffeine can cause nervousness, irritability, insomnia, and occasionally, rapid heartbeat.
Pregnancy, breastfeeding, and fertility
The use of this medicine is not recommended during pregnancy. If you are pregnant or think you may be pregnant, consult your doctor and do not take Excedite.
Pregnancy - last trimester
Do not take this medicine in the last 3 months of pregnancy, as it can cause harm to the baby before birth and problems during delivery due to its content of acetylsalicylic acid. It can cause problems in the fetus's kidneys and heart. It can affect your coagulation and that of your baby, leading to delayed or prolonged delivery.
Pregnancy - first and second trimester
Due to its content of acetylsalicylic acid, you should not take this medicine during the first 6 months of pregnancy unless it is absolutely necessary and has been recommended by your doctor. If you need to use this treatment during this period of pregnancy or while trying to become pregnant, you should use the lowest possible dose for the shortest possible time. If taken for more than a few days from week 20 of pregnancy onwards, acetylsalicylic acid can cause kidney problems in your baby before birth, leading to a lower than normal amount of amniotic fluid around the fetus (oligohydramniosis) or narrowing of a blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for more than a few days, your doctor may recommend additional monitoring.
Women who are breastfeeding should not take this medicine, as it can be harmful to their baby.
Consult your doctor or pharmacist before using any medicine.
Excedite belongs to a group of medicines (NSAIDs) that can reduce fertility in women. Although this effect is reversible when you stop taking the medicine.
Driving and using machines
Excedite does not affect the ability to drive or use machines. If you notice side effects such as dizziness or drowsiness, do not drive vehicles or operate machinery and consult your doctor as soon as possible.
Follow the instructions for taking this medicine exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.
Adults (18 years of age or older):
Take 1 tablet with a full glass of water when the pain appears. If necessary, you can take another tablet 4 to 6 hours later.
If the pain is more intense, take 2 tablets with a full glass of water when the pain appears. If necessary, you can take 2 more tablets 4 to 6 hours later.
Do not use this medicine for more than 4 days for headache without consulting your doctor.
Take 2 tablets with a full glass of water when migraine symptoms appear. If necessary, you can take 2 more tablets 4 to 6 hours later.
If you do not notice relief within 2 hours after the first dose of 2 Excedite tablets, consult your doctor.
Do not use this medicine for more than 3 days for migraine without consulting your doctor.
For both headache and migraine treatment, do not take more than 6 tablets in 24 hours. This corresponds to a dose of 1500 mg of acetylsalicylic acid, 1500 mg of paracetamol, and 390 mg of caffeine.
Prolonged use without medical supervision can be harmful.
Do not take more than the indicated dose. Use the lowest dose that you need to treat your symptoms and use this medicine for the shortest time necessary.
Children and adolescents:
This medicine should not be administered to children and adolescents under 18 years of age (see Take special care with Excedite)
Elderly patients (over 65 years of age):
There are no special recommendations. If you have a low body weight, you should consult your doctor or pharmacist.
Patient with liver or kidney problems:
Consult your doctor if you have liver or kidney problems. It may be necessary to adjust the dose, intervals, or duration of treatment. Do not take this medicine if you have serious kidney or liver problems.
If you take more Excedite than you should
These tablets contain acetylsalicylic acid, paracetamol, and caffeine. Do not take more than the recommended dose and do not use any other product that contains these ingredients or other non-steroidal anti-inflammatory drugs while taking Excedite.
Contact your doctor, pharmacist, or go to the nearest hospital as soon as possible if you think you have taken an overdose. Immediate medical attention is critical due to the potential risk of irreversible liver damage due to paracetamol. Do not wait for symptoms to appear, as an overdose may not initially produce noticeable symptoms.
In case of overdose or accidental ingestion, go to a medical centre immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
The symptoms of overdose are:
Even if these symptoms do not appear or have disappeared, it is very important to seek medical help immediately.
In case of overdose or accidental ingestion, go to a medical centre immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Excedite
Take the dose as soon as you can, do not take a double dose to make up for forgotten doses.
Do not take more than 6 tablets a day.
Consult your doctor or pharmacist in case of doubts about the use of this medicine.
In case of overdose or accidental ingestion, go to a medical centre immediately or call the Toxicology Information Service (Telephone 91 562 04 20), indicating the medicine and the amount taken.
Like all medications, Excedite can produce adverse effects, although not all people suffer from them.
Suspend treatment with Excedite and inform your doctor if you suffer from any of the following adverse effects:
The following adverse effects were recorded in the 16 clinical trials conducted with Excedite on 4800 treated subjects. Consult your doctor if you notice any of the following adverse effects:
Frequent (Affects 1 to 10 out of every 100 patients):
Infrequent (Affects 1 to 10 out of every 1000 patients):
Rare (Affects 1 to 10 out of every 10,000 patients):
Frequency not known (cannot be estimated from available data):
The following adverse effects have been reported during the marketing of the medication. In general, the frequency in post-marketing surveillance cannot be determined precisely, so it is indicated as "unknown".
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
Do not use after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Excedite
Each film-coated tablet contains 250 mg of acetylsalicylic acid, 250 mg of paracetamol, and 65 mg of caffeine.
Core of the tablet:low-substituted hydroxypropylcellulose, microcrystalline cellulose (E460), stearic acid.
Coating:hypromellose (E464), titanium dioxide (E171), propylene glycol, benzoic acid (E210), carnauba wax (E903).
Appearance of Excedite and Packaging Content
White, oblong-shaped, film-coated tablet with an "E" marked on one of its faces.
The tablets are presented in blisters that are packaged in boxes containing 10, 16, 20, 30, and 32 film-coated tablets. Not all packaging sizes may be marketed.
Marketing Authorization Holder
Haleon Spain, S.A.
Paseo de la Castellana, 259D, 32nd floor - 28046 – Madrid – Spain
Manufacturer
GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
Barthstrasse, 4 - 80339
Munich (Germany)
Or
GlaxoSmithKline Consumer Healthcare Sp. z o.o.,
Gnatowice Stare 30, 05-085 Kampinos, Poland
Or
GLAXOSMITHKLINE CONSUMER HEALTHCARE
Address:ul. Rzymowskiego 53 - Warszawa - 02-697 – Poland
Or
Famar Italia S.P.A
Via Zambeletti, 25, 20021 Baranzate (MI), Italy
Or
Haleon Germany GmbH
Barthstrasse, 4 - 80339
Munich (Germany)
This medication is authorized in EEA member states under the following names:
Belgium: Excedryn, film-coated tablets
Cyprus: Panmigran
Bulgaria: Excedrin 250mg / 250mg / 65mg ????????? ????????
Germany: Paracetamol/ASS/Coffein Kopfschmerz & Migräne 250mg/250mg/65mg Filmtabletten
Greece: Excedrin
Ireland: Excedrin film-coated tablets
Luxembourg: Excedryn, film-coated tablets
Malta: Panmigran
Netherlands: Excedrin, film-coated tablets
Poland: Excedrin MigraStop
Portugal: Excedrin
Slovakia: Excedrin
Slovakia: Excedrin
Date of the last revision of this prospectus: June 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/